Nanopublications LDF server

Matches in Nanopublications for { ?s ?p "[A single administration of rAd-GLP-1 via the tail vein into streptozotocin (STZ)-induced diabetic non-obese diabetic/severe combined immunodeficient (NOD/SCID) mice resulted in remission of diabetes within 10 days; normoglycemia remained until the experiment was terminated.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine."@en ?g. }

• assertion description "[A single administration of rAd-GLP-1 via the tail vein into streptozotocin (STZ)-induced diabetic non-obese diabetic/severe combined immunodeficient (NOD/SCID) mice resulted in remission of diabetes within 10 days; normoglycemia remained until the experiment was terminated.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• assertion description "[A single administration of rAd-GLP-1 via the tail vein into streptozotocin (STZ)-induced diabetic non-obese diabetic/severe combined immunodeficient (NOD/SCID) mice resulted in remission of diabetes within 10 days; normoglycemia remained until the experiment was terminated.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• assertion description "[A single administration of rAd-GLP-1 via the tail vein into streptozotocin (STZ)-induced diabetic non-obese diabetic/severe combined immunodeficient (NOD/SCID) mice resulted in remission of diabetes within 10 days; normoglycemia remained until the experiment was terminated.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• assertion description "[A single administration of rAd-GLP-1 via the tail vein into streptozotocin (STZ)-induced diabetic non-obese diabetic/severe combined immunodeficient (NOD/SCID) mice resulted in remission of diabetes within 10 days; normoglycemia remained until the experiment was terminated.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• NP584041.RA3atPAf3eu-810xC0Ca8x0QAo0FfvayEZpF2lJ6ilHaQ130_assertion description "[A single administration of rAd-GLP-1 via the tail vein into streptozotocin (STZ)-induced diabetic non-obese diabetic/severe combined immunodeficient (NOD/SCID) mice resulted in remission of diabetes within 10 days; normoglycemia remained until the experiment was terminated.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP584041.RA3atPAf3eu-810xC0Ca8x0QAo0FfvayEZpF2lJ6ilHaQ130_provenance.
• NP584042.RA0DqzJJ1BTpzxf8YN4MKgbZ4MQoNmNIgLk6Kw8kjYdws130_assertion description "[A single administration of rAd-GLP-1 via the tail vein into streptozotocin (STZ)-induced diabetic non-obese diabetic/severe combined immunodeficient (NOD/SCID) mice resulted in remission of diabetes within 10 days; normoglycemia remained until the experiment was terminated.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP584042.RA0DqzJJ1BTpzxf8YN4MKgbZ4MQoNmNIgLk6Kw8kjYdws130_provenance.
• NP584043.RA3NT-BWNuFVrJvkRXtk2PAJ3H86ZCQa79cPuDWgX_LWU130_assertion description "[A single administration of rAd-GLP-1 via the tail vein into streptozotocin (STZ)-induced diabetic non-obese diabetic/severe combined immunodeficient (NOD/SCID) mice resulted in remission of diabetes within 10 days; normoglycemia remained until the experiment was terminated.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP584043.RA3NT-BWNuFVrJvkRXtk2PAJ3H86ZCQa79cPuDWgX_LWU130_provenance.
• NP584046.RA3EeKirbt7fZk4aOOX3gPxz55eHig9B5AXw-pj3wRScc130_assertion description "[A single administration of rAd-GLP-1 via the tail vein into streptozotocin (STZ)-induced diabetic non-obese diabetic/severe combined immunodeficient (NOD/SCID) mice resulted in remission of diabetes within 10 days; normoglycemia remained until the experiment was terminated.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP584046.RA3EeKirbt7fZk4aOOX3gPxz55eHig9B5AXw-pj3wRScc130_provenance.
• NP584040.RAXtMhuyqlNW2AklZXiciH8rWJ50fV1J9YrA0YPI-HE8w130_assertion description "[A single administration of rAd-GLP-1 via the tail vein into streptozotocin (STZ)-induced diabetic non-obese diabetic/severe combined immunodeficient (NOD/SCID) mice resulted in remission of diabetes within 10 days; normoglycemia remained until the experiment was terminated.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP584040.RAXtMhuyqlNW2AklZXiciH8rWJ50fV1J9YrA0YPI-HE8w130_provenance.
• assertion description "[A single administration of rAd-GLP-1 via the tail vein into streptozotocin (STZ)-induced diabetic non-obese diabetic/severe combined immunodeficient (NOD/SCID) mice resulted in remission of diabetes within 10 days; normoglycemia remained until the experiment was terminated.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• assertion description "[A single administration of rAd-GLP-1 via the tail vein into streptozotocin (STZ)-induced diabetic non-obese diabetic/severe combined immunodeficient (NOD/SCID) mice resulted in remission of diabetes within 10 days; normoglycemia remained until the experiment was terminated.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• assertion description "[A single administration of rAd-GLP-1 via the tail vein into streptozotocin (STZ)-induced diabetic non-obese diabetic/severe combined immunodeficient (NOD/SCID) mice resulted in remission of diabetes within 10 days; normoglycemia remained until the experiment was terminated.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• assertion description "[A single administration of rAd-GLP-1 via the tail vein into streptozotocin (STZ)-induced diabetic non-obese diabetic/severe combined immunodeficient (NOD/SCID) mice resulted in remission of diabetes within 10 days; normoglycemia remained until the experiment was terminated.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• NP584052.RAJiYyOgAHMAKTb5LLJJy1Q1TxPAUxqRfOiqZgzFSTdBs130_assertion description "[A single administration of rAd-GLP-1 via the tail vein into streptozotocin (STZ)-induced diabetic non-obese diabetic/severe combined immunodeficient (NOD/SCID) mice resulted in remission of diabetes within 10 days; normoglycemia remained until the experiment was terminated.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP584052.RAJiYyOgAHMAKTb5LLJJy1Q1TxPAUxqRfOiqZgzFSTdBs130_provenance.